Examining the Controversy Surrounding Ozempic and Healthcare Corruption

This chapter examines the contentious endorsement of Ozempic as a primary treatment for overweight adolescents by the American Academy of Pediatrics. It critiques the influence of pharmaceutical marketing on healthcare decisions and public perceptions, emphasizing the intersection of health, economics, and civil rights in medical recommendations.